{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T04:38:22Z","timestamp":1783053502034,"version":"3.54.6"},"reference-count":28,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2010,4,15]],"date-time":"2010-04-15T00:00:00Z","timestamp":1271289600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2010,11]]},"abstract":"<jats:sec>\n                    <jats:label\/>\n                    <jats:p>Study Type \u2013 Diagnosis (validating cohort)\u2028Level of Evidence\u20031b<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To identify prognostic risk factors for the development of subsequent bladder recurrence in patients undergoing nephroureterectomy (NU) for upper tract transitional cell carcinoma (TCC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PATIENTS AND METHODS<\/jats:title>\n                    <jats:p>\n                      The data of 79 patients who underwent NU for localized upper tract TCC were collected retrospectively, and analysed for clinical and pathological variables. Patients with previous invasive bladder tumours were excluded. Age, sex, tumour location, previous\/synchronic bladder tumours, stage, grade, concomitant upper tract carcinoma\n                      <jats:italic>in situ<\/jats:italic>\n                      (CIS), and size were all analysed. Univariate and multivariate analyses were done using the Kaplan\u2010Meier Method, with the log\u2010rank test, and the Cox proportional hazards regression model, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      The median follow\u2010up was 71 months, during which bladder tumours were detected in 42 patients (54%). On univariate analyses, tumour stage \u2265 pT2 (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.015), concomitant upper tract CIS (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.001), high\u2010grade tumour G3 (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.027) and tumour size &gt;4\u2003cm (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.011) were statistically significant predictors of intravesical recurrence. After multivariate analyses, concomitant CIS (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.005, hazard ratio 2.9, 95% confidence interval 1.4\u20135.8) and tumour size &gt;4\u2003cm (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.042; 1.9, 1\u20133.7) were significantly related to bladder tumour recurrence.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>There is a high bladder recurrence rate after NU for upper tract TCC. Patients with tumours of &gt;4\u2003cm and concomitant upper tract CIS have a major risk of developing subsequent bladder recurrence. Therefore, closer surveillance of the bladder is needed in these patients and they may potentially benefit from prophylactic intravesical instillation therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1464-410x.2010.09341.x","type":"journal-article","created":{"date-parts":[[2010,4,15]],"date-time":"2010-04-15T12:23:33Z","timestamp":1271334213000},"page":"1319-1323","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Concomitant carcinoma\n                    <i>in situ<\/i>\n                    and tumour size are prognostic factors for bladder recurrence after nephroureterectomy for upper tract transitional cell carcinoma"],"prefix":"10.1111","volume":"106","author":[{"given":"Enrique","family":"Pieras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Frontera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavi","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Vicens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Ozonas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Piz\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,4,15]]},"reference":[{"key":"e_1_2_7_2_2","first-page":"2383","volume-title":"Campbell\u2019s Urology","author":"Messing EM","year":"1998"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-2042.2001.00315.x"},{"key":"e_1_2_7_4_2","first-page":"243","article-title":"Carcinomas uroteliales del tracto urinario superior. Supervivencia y factores pron\u00f3sticos","volume":"51","author":"Arrizabalaga M","year":"1998","journal-title":"Arch Esp Urol"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1159\/000471683"},{"key":"e_1_2_7_6_2","first-page":"428","article-title":"A clinical study of renal pelvis and ureteral cancer: prognosis and frequency of subsequent bladder cancer following surgical treatment","volume":"94","author":"Watanabe M","year":"2003","journal-title":"Nippon Hinyokika Gakkai Zasshi"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2005.05804.x"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2004.09.021"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11691"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.1991.tb15064.x"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1159\/000050969"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1159\/000080829"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)67975-X"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(94)E0133-O"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)90117-4"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.3.1099"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000132128.79974.db"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(96)00571-7"},{"key":"e_1_2_7_19_2","first-page":"187","volume-title":"TNM Classification of Malignant Tumors","author":"International Union Against Cancer (UICC)","year":"1997"},{"key":"e_1_2_7_20_2","volume-title":"Histological Typing of Urinary Bladder Tumours. International Classification of Tumours, 19","author":"Mostofi FK","year":"1973"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2008.07438.x"},{"key":"e_1_2_7_22_2","article-title":"Bladder recurrence after nephroureterectomy in patients with urothelial carcinoma of the upper urinary tract","author":"Ku JH","year":"2009","journal-title":"Urol Oncol"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)52871-2"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24135"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)55269-6"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1015-9584(08)60050-0"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(99)00563-4"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2007.08.054"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.2009.02420.x"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1464-410X.2010.09341.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1464-410X.2010.09341.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:17:39Z","timestamp":1761743859000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1111\/j.1464-410X.2010.09341.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,15]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["10.1111\/j.1464-410X.2010.09341.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1464-410x.2010.09341.x","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"value":"1464-4096","type":"print"},{"value":"1464-410X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,15]]},"assertion":[{"value":"2010-04-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}